The Venture Codex Logo

The Venture Codex

Overview

Peptide drug development with improved safety and efficacy.

Total Raised

$10 M

Rounds

1

Links

Verticals

Biotechnology
Pharmaceutical
Therapeutics

Investment History

  1. Series B

    Jan 2023

    $10M

Team

Jake Halliday

Chief Executive Officer

Kenneth Gruber

Founder, President & Chief Scientific Officer

Daniel Marks

Chief Medical Officer

LeAnn Qi

Chief Commercialization Officer